Evidence map›Paper›PMID 30171682›Full record

ArticleJournal of cellular physiology2019

Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart.

Yu Tina Zhao, Jianguo Wang, Naohiro Yano, Ling X Zhang, Hao Wang, Shouyan Zhang, Gangjian Qin, Patrycja M Dubielecka, Shougang Zhuang, Paul Y Liu and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Therapeutic Potential of Irisin in Neurodegenerative Diseases.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. The Emerging Role of Irisin in Cardiovascular Diseases.Journal of the American Heart Association · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Yu Tina ZhaoDepartment of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island.
Jianguo WangDepartment of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island.
Naohiro Yano
Ling X ZhangDepartment of Medicine, Rhode Island Hospital, Brown University, Providence, Rhode Island.
Hao WangDepartment of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island.
Shouyan ZhangDepartment of Medicine, Luoyang Central Hospital, Zhengzhou University, Luoyang, China.
Gangjian QinDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
Patrycja M DubieleckaDepartment of Medicine, Rhode Island Hospital, Brown University, Providence, Rhode Island.
Shougang ZhuangDepartment of Medicine, Rhode Island Hospital, Brown University, Providence, Rhode Island.
Paul Y LiuDepartment of Plastic Surgery, Rhode Island Hospital, Brown University, Providence, Rhode Island.
Y Eugene ChinKey Laboratory of Stem Cell Biology, Institute of Health Sciences, Chinese Academy of Sciences-Jiaotong University School of Medicine, Shanghai, China.
Ting C ZhaoDepartment of Surgery, Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island.ORCID 0000-0001-6376-0275
Boston University · USBrown University · USChinese Academy of Sciences · CNLuoyang Central Hospital Affiliated to Zhengzhou University · CNUniversity of Alabama at Birmingham · US

Funding

Histone Deacetylase Inhibition: A Novel Approach to CardioprotectionR01HL089405 · NHLBI · ROGER WILLIAMS MEDICAL CENTER · PI ZHAO, TING C · 2009 to 2020
$3.4M
p38 acetylation: Novel signaling mechanisms and myocardial protectionR01HL115265 · NHLBI · ROGER WILLIAMS MEDICAL CENTER · PI ZHAO, TING C · 2013 to 2016
$1.6M
NHLBI NIH HHS R01 HL089405NHLBI NIH HHS R01 HL115265
6 · The paper itself

Abstract

Irisin, a newly identified hormone and cardiokine, is critical for modulating body metabolism. New evidence indicates that irisin protects the heart against myocardial ischemic injury. However, whether irisin enhances cardiac progenitor cell (CPC)-induced cardiac repair remains unknown. This study examines the effect of irisin on CPC-induced cardiac repair when these cells are introduced into the infarcted myocardium. Nkx2.5

Indexed as

RegenerationVentricular Function, LeftAnimalsApoptosisCell ProliferationCells, CulturedDisease Models, AnimalFibronectinsFibrosisHomeobox Protein Nkx-2.5MaleMiceMice, Inbred ICRMouse Embryonic Stem CellsMyocardial InfarctionMyocytes, CardiacFibronectinsHomeobox Protein Nkx-2.5cardiac progenitor cellirisinmyocardial infarctionventricular function

Identifiers

PMID30171682
PMCPMC6510276
OpenAlexW2888876244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.